Assessing the Spleen as an Organ at Risk in Radiation Therapy and Its Relationship With Radiation-Induced Lymphopenia: A Retrospective Study and Literature Review

Abstract

Purpose We conducted a systematic review and a retrospective study to investigate the relationship between spleen irradiation and lymphocyte toxicity. Methods and Materials Forty-six patients diagnosed with locally advanced gastric, esophageal, and pancreatic cancer who underwent radiation therapy were included in this study. The spleen was contoured for each patient. Volumes that received 5 up to 40 Gy (5 Gy increments), minimum, mean, and maximum dose were considered along with lymphocyte count to determine toxicity. Comprehensive and systematic literature searches were performed using PubMed, SCOPUS, Cochrane Central Databases, and Google Scholar. Results Literature review on spleen unintended irradiation and lymphocyte toxicity resulted in 408 patients from 5 studies. In our study, univariate and multivariate linear regressions found an association between V15 (chemotherapy as controlling factor) and nadir lymphocyte count ( P = .04) and between D MAX and nadir lymphocyte count ( P = .046). An increase of 1 Gy in mean splenic dose was associated with a 1% decrease in absolute lymphocyte count at nadir. Conclusions Although there is no consensus regarding lymphopenia spleen dose volume threshold, all studies found that higher splenic dose increases the risk of lymphopenia. Our study's results suggest that spleen unintentional V15 and maximum dose irradiation were associated with lymphopenia during chemoradiation therapy.

Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis

“…However, there might be more organs to account for, such as the spleen. A study showed that higher splenic dose increases the risk of lymphopenia in a series of upper abdominal cancers, including EC [ 47 , 48 ]. Saito et al showed that when the mean splenic dose increased by 1 Gy, the predicted ALC decreased by 2.9% in EC patients [ 49 ].…”

Blood Group Type Association with Head and Neck Cancer

“…Moreover, genome-wide association studies [ 34 , 35 , 36 ] failed to link ABO blood groups to NPC risk. It is already widely accepted that lymphocyte counts are important prognostic factors for cancer patients [ 37 , 38 , 39 , 40 ]. The study of Zhang Y et al [ 32 ] is the only one to evaluate the link between the ABO blood group, tumor stage and blood lymphocyte counts.…”

The Microbiota and the Relationship with Colorectal Cancer: Surgical Complications—A Review

“…One other possible mechanism might involve surgical stress, which could promote contamination of microbiota with skin bacteria and lead to the disruption of the local T lymphocytes, thus creating an increased risk of SSI [56,62,63].…”